Glutaminase-IN-1;CB839 derivative;Glutamise-IN-1;Glutaminase inhibitor 1;2-Pyridineacetamide, N-[5-[4-[6-[[2-[3-(trifluoromethoxy)phenyl]acetyl]amino]-3-pyridazinyl]butyl]-1,3,4-selenadiazol-2-yl]-;GlutaminaseIN1,Glutaminase IN 1;Glutaminase-IN-1, 10 mM in DMSO
Glutaminase-IN-1 (CB839 derivative) is an allosteric inhibitor of kidney-type glutaminase (KGA) with an IC50 of 1 nM; it enhances cellular uptake and exhibits antitumor activity.